Diffusion and Perfusion MR Imaging of the Prostate

Magnetic Resonance Imaging Clinics of North America

Volumn 16, Issue 4, 2008, Pages 685-695

  Somford, Diederik M ^a   Fütterer, Jurgen J ^a   Hambrock, Thomas ^a   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Diffusion; Magnetic resonance; Perfusion; Prostate cancer

Indexed keywords

CONTRAST MEDIUM;

ANGIOGENESIS; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; PERFUSION WEIGHTED IMAGING; PROSTATE; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATITIS; REVIEW; TUMOR GROWTH;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 52949137426     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2008.07.002     Document Type: Review

References (66)

1. Crank J. The mathematics of diffusion (1956), Oxford University Press, New York
2. Stejskal E.O., and Tanner J.E. Spin diffusion measurements: spin echoes in the presence of a time-dependent field-gradient. J Chem Phys 42 (1965) 288-292
3. Basser P.J., Mattiello J., and LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson 103 (1994) 247-254
4. Bammer R., Skare S., Newbould R., et al. Foundations of advanced magnetic resonance imaging. NeuroRx 2 (2005) 167-195
5. Basser P.J. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 8 (1995) 333-344
6. Westin C.F., Maier S.E., Mamata H., et al. Processing and visualization for diffusion tensor MRI. Med Image Anal 6 (2002) 93-108
7. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 45 (2003) 169-184
8. Schaefer P.W., Copen W.A., Lev M.H., et al. Diffusion-weighted imaging in acute stroke. Magn Reson Imaging Clin N Am 14 (2006) 141-168
9. Moseley M.E., Butts K., Yenari M.A., et al. Clinical aspects of DWI. NMR Biomed 8 (1995) 387-396
10. Moseley M.E., Kucharczyk J., Mintorovitch J., et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted imaging and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 11 (1990) 423-429
11. Lansberg M.G., Norbash A.M., Marks M.P., et al. Advantages of adding diffusion-weighted magnetic resonance imaging to conventional magnetic resonance imaging for evaluating acute stroke. Arch Neurol 57 (2000) 1311-1316
12. Anderson A.W., Xie J., Pizzonia J., et al. Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging 18 (2000) 689-695
13. Kumar V., Jagannathan N.R., Kumar R., et al. Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone. NMR Biomed 20 (2007) 505-511
14. Kim C.K., Park B.K., Lee H.M., et al. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol 42 (2007) 842-847
15. Tamada T., Sone T., Toshimutsu S., et al. Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. J Magn Reson Imaging 27 (2008) 552-556
16. Hricak H., Dooms G.C., McNeal J.E., et al. MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol 148 (1987) 51-58
17. Allen K.S., Kressel H.Y., Arger P.H., et al. Age-related changes of the prostate: evaluation by MR imaging. AJR Am J Roentgenol 152 (1989) 77-81
18. Ren J., Huan Y., Wang H., et al. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases. Abdom Imaging (2008) [Epub ahead of print]
19. Song S.K., Qu Z., Garabedian E.M., et al. Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res 62 (2002) 1555-1558
20. Manenti G., Carlani M., Mancino S., et al. Diffusion tensor magnetic resonance imaging of prostate cancer. Invest Radiol 42 (2007) 412-419
21. Gibbs P., Pickles M.D., and Turnbull L.W. Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol 41 (2006) 185-188
22. White S., Hricak H., Forstner R., et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195 (1995) 385-390
23. Rajesh A., and Coakley F.V. MR imaging and MR spectroscopic imaging of prostate cancer. Magn Reson Imaging Clin N Am 12 (2004) 557-579
24. Fütterer J.J., Heijmink S.W., and Spermon J.R. Imaging the male reproductive tract: current trends and future directions. Radiol Clin North Am 46 (2008) 133-147
25. Haider M.A., van der Kwast T.H., Tanguay J., et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189 (2007) 323-328
26. Fütterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 (2006) 449-458
27. Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 78 (2005) 103-111
28. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 654-661
29. Shimofusa R., Fujimoto H., Akamata H., et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 29 (2005) 149-153
30. Miao H., Fukatsu H., and Ishigaki T. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 61 (2007) 297-302
31. Morgan V.A., Kyriazi S., Ashley S.E., et al. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol 48 (2007) 695-703
32. Tanimoto A., Nakashima J., Kohno H., et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. Magn Reson Imaging 25 (2007) 146-152
33. Albertsen P.C., Hanley J.A., Gleason D.F., et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280 (1998) 975-980
34. Desireddi N.V., Roehl K.A., Loeb S., et al. Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era. Urology 70 (2007) 950-955
35. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555-565
36. Roach III M., Weinberg V., Sandler H., et al. Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?. Cancer 109 (2007) 213-220
37. de Vries S.H., Postma R., Raaijmakers R., et al. Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam. Eur Urol 51 (2007) 366-374
38. Ruijter E.T., Van de Kaa C.A., Schalken J.A., et al. Histological heterogeneity in multifocal prostate cancer: biological and clinical implications. J Pathol 180 (1996) 295-299
39. Noguchi M., Stamey T.A., McNeal J.E., et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 166 (2001) 104-109
40. Grossklaus D.J., Coffey C.S., Shappel S.B., et al. Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores. BJU Int 88 (2001) 722-726
41. Wang L., Masaheri Y., Zhang J., et al. Assessment of biological aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology 246 (2008) 168-176
42. Nakanishi K., Kobayashi M., Nakaguchi K., et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 6 3 (2007) 147-155
43. Nemeth A.J., Henson J.W., Mullins M.E., et al. Improved detection of skull metastasis with diffusion-weighted MR imaging. AJNR Am J Neuroradiol 28 6 (2007) 1088-1092
44. Cornfeld D.M., and Weinreb J.C. MR imaging of the prostate: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15 (2007) 433-448
45. Matsuoka A., Minato M., Harada M., et al. Comparison of 3.0- and 1.5-Tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 26 (2008) 15-20
46. Heijmink S.W., Fütterer J.J., Hambrock T., et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology 244 (2007) 184-195
47. Futterer J.J., Engelbrecht M.R., Jager G.J., et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils: local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17 (2007) 1055-1065
48. Fütterer J.J., Engelbrecht M.R., Huisman H.J., et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237 (2005) 541-549
49. Padhani A.R., Harvey C.J., and Cosgrove D.O. Angiogenesis imaging in the management of prostate cancer. Nat Clin Pract Urol 2 (2005) 596-607
50. Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 32A (1996) 2534-2539
51. Alonzi R., Padhani A., and Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63 (2007) 335-350
52. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
53. Jackson M.W., Bentel J.M., and Tilley W.D. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol 157 (1997) 2323-2328
54. Jain R.K., Safabakhsh N., Sckell A., et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci U S A 95 (1998) 10820-10825
55. Collins D.J., and Padhani A.R. Dynamic magnetic resonance imaging of tumor perfusion. IEEE Eng Med Biol Mag 23 (2004) 65-83
56. d'Arcy J.A., Collins D.J., Padhani A.R., et al. Informatics in radiology (infoRAD): magnetic resonance imaging workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data. Radiographics 26 (2006) 621-632
57. Sorensen A.G., Tievsky A.L., Ostergaard L., et al. Contrast agents in functional MR imaging. J Magn Reson Imaging 7 (1997) 47-55
58. Barbier E.L., Lamalle L., and Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 13 (2001) 496-520
59. Huisman H.J., Engelbrecht M.R., and Barentsz J.O. Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 13 (2001) 607-614
60. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
61. Rijpkema M., Kaanders J.H., Joosten F.B., et al. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 14 (2001) 457-463
62. Hara N., Okuizumi M., Koike H., et al. Dynamic contrast-enhanced MR imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62 (2005) 140-147
63. Beyersdorff D., Taupitz M., Winkelmann B., et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 224 (2002) 701-706
64. Haider M.A., Chung P., Sweet J., et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 425-430
65. Sciarra A., Panebianco V., Di Silverio F., et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 54 3 (2008) 485-488
66. Puech P., Betrouni N., Viard R., et al. Prostate cancer computer-assisted diagnosis software using dynamic contrast-enhanced MRI. Conf Proc IEEE Eng Med Biol Soc 2007 (2007) 5567-5570